arginyl-glycyl-aspartic acid has been researched along with Cancer of Larynx in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, Y; Lv, L; Ning, SX; Wang, JH; Xiao, R | 1 |
| Chen, X; Fan, Y; Liu, W; Liu, X; Wang, N; Wu, D; Yan, H; Zhang, X; Zhao, Z | 1 |
| Jiang, J; Lv, L; Lv, M; Shao, F; Wang, J; Wang, Y; Zheng, Y | 1 |
3 other study(ies) available for arginyl-glycyl-aspartic acid and Cancer of Larynx
| Article | Year |
|---|---|
The Anti-tumor Activity and Mechanisms of rLj-RGD3 on Human Laryngeal Squamous Carcinoma Hep2 Cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Laryngeal Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Structure-Activity Relationship | 2019 |
Fluorescence imaging-guided multifunctional liposomes for tumor-specific phototherapy for laryngeal carcinoma.
Topics: Animals; Cell Line, Tumor; Coloring Agents; Humans; Indocyanine Green; Laryngeal Neoplasms; Lasers; Liposomes; Male; Mice, SCID; Oligopeptides; Optical Imaging; Phosphatidylethanolamines; Phototherapy; Polyethylene Glycols; Reactive Oxygen Species | 2020 |
The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice.
Topics: Amino Acid Motifs; Angiogenesis Inhibitors; Animals; Apoptosis; Body Weight; Carcinoma, Squamous Cell; Cell Line, Tumor; Fish Proteins; Fish Venoms; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Lampreys; Laryngeal Neoplasms; Marine Toxins; Mice, Nude; Microvessels; Oligopeptides; Random Allocation; Recombinant Proteins; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |